Skip to content

The 10 most active techbio investors in Europe – Sifted

The 10 most active techbio investors in Europe – Sifted

From drug discovery platforms to novel cancer treatments, techbio startups are working to revolutionise healthcare for patients — and the industry in Europe raised around $5.7bn in 2022 to do so, according to Dealroom. Though that’s $300m less than it raised in 2021, the funding has potential to bounce back: in Q2 of 2023 the sector drummed up $1.8bn across Europe, the highest quarterly total since Q1 of last year.  Certain investors have been particularly active in pouring cash into techbio despite the downturn, contributing to the sector’s gradual resurgence.Here are the most active investors in the techbio space since January 2022 by… 

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *